Pharmaceutical companies are optimistic about growth under the Trump administration, with hopes for a pro-business approach focusing on cracking down on pharmacy benefit managers and promoting drug innovation. Executives at the JPMorgan Health Care Conference expressed readiness to work with Trump, despite uncertainties around his administration, such as concerns about the anti-vaccine views of Robert F. Kennedy Jr., Trump’s pick for the Department of Health and Human Services. Overall, the industry is prepared to engage with the new administration and navigate potential challenges in the coming years.
Full Article
Hoover’s FBI and the Dangers of Blind Obedience
J. Edgar Hoover, first director of the FBI, exemplified authoritarian leadership, often leading to misinterpretations of his ambiguous directives, as seen in his infamous note on "watching the borders" regarding margin sizes. This highlights the significant impact of authority bias and the importance for leaders to communicate clearly to prevent chaos and ensure effective decision-making within organizations. Want More Context? 🔎
Read more